DAPAGLIFLOZIN MODULATES ADROPIN SERUM LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE

被引:0
|
作者
Berezin, Alexander [1 ]
Fushtey, Ivan M. [2 ]
Berezin, Alexander A. [2 ]
机构
[1] State Med Univ, Dept Internal Med, Zaporozhe, Ukraine
[2] Med Acad Postgrad Educ, Dept Internal Med, Zaporozhe, Ukraine
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
下载
收藏
页码:E100 / E100
页数:1
相关论文
共 50 条
  • [21] Oxidative stress in patients with chronic heart failure and type 2 diabetes mellitus
    Arzamastseva, N. E.
    Lankin, V. Z.
    Konovalova, G. G.
    Tikhaze, A. K.
    Ageev, F. T.
    Lapina, V.
    Narusov, O. Yu.
    Mareev, V. Yu.
    Belenkov, Yu. N.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 143 (02) : 207 - 209
  • [22] Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
    Berezin, Alexander A.
    Lichtenauer, Michael
    Boxhammer, Elke
    Fushtey, Ivan M.
    Berezin, Alexander E. E.
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [23] Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure
    Berezin, Alexander A.
    Obradovic, Anica Babic
    Fushtey, Ivan M.
    Berezina, Tetiana A.
    Lichtenauer, Michael
    Berezin, Alexander E.
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (04)
  • [24] Relationship between serum adropin and carotid atherosclerosis in patients with type 2 diabetes mellitus
    Zang, Huanhuan
    Cheng, Xingbo
    Jiang, Fusong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33
  • [25] Heart failure in patients with type 2 diabetes mellitus
    Vlad, Adrian
    Serban, Viorel
    Timar, Romulus
    Darabantiu, Dan
    DIABETES, 2007, 56 : A588 - A588
  • [26] Dapagliflozin pharmacokinetics is similar between patients with heart failure with reduced ejection fraction and patients with type 2 diabetes mellitus
    Melin, Johanna
    Parkinson, Joanna
    Hamren, Bengt
    Penland, Robert C.
    Boulton, David W.
    Tang, Weifeng
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (02) : 606 - 612
  • [27] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) and Concomitant Heart Failure
    Kosiborod, Mikhail
    Gause-Nilsson, Ingrid Ami
    Sonesson, Christian
    Sugg, Jennifer E.
    Johnsson, Eva
    DIABETES, 2015, 64 : A313 - A313
  • [28] Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure
    Fumitaka Soga
    Hidekazu Tanaka
    Kazuhiro Tatsumi
    Yasuhide Mochizuki
    Hiroyuki Sano
    Hiromi Toki
    Kensuke Matsumoto
    Junya Shite
    Hideyuki Takaoka
    Tomofumi Doi
    Ken-ichi Hirata
    Cardiovascular Diabetology, 17
  • [29] PREDICTORS OF KIDNEY EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CHRONIC HEART FAILURE PATIENTS
    Berezin, Alexander
    Fushtey, Ivan
    Berezina, Tetiana
    Berezin, Oleksandr
    JOURNAL OF HYPERTENSION, 2024, 42
  • [30] EFFECT OF DAPAGLIFLOZIN ON LEFT VENTRICULAR DIASTOLIC FUNCTION OF PATIENTS WITH TYPE 2 DIABETIC MELLITUS WITH CHRONIC HEART FAILURE
    Soga, Fumitaka
    Tanaka, Hidekazu
    Tatsumi, Kazuhiro
    Mochizuki, Yasuhide
    Sano, Hiroyuki
    Toki, Hiromi
    Matsumoto, Kensuke
    Shite, Junya
    Takaoka, Hideyuki
    Doi, Tomofumi
    Hirata, Ken-Ichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 815 - 815